--- title: "Best Pharmaceutical Stocks To Watch Now - July 25th" type: "News" locale: "en" url: "https://longbridge.com/en/news/293827703.md" description: "MarketBeat's stock screener identifies Eli Lilly, AbbVie, Abbott Laboratories, Bristol Myers Squibb, and Gilead Sciences as the top five pharmaceutical stocks to watch on July 25th. These companies were selected based on having the highest dollar trading volume among pharmaceutical stocks in recent days." datetime: "2026-07-25T18:01:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293827703.md) - [en](https://longbridge.com/en/news/293827703.md) - [zh-HK](https://longbridge.com/zh-HK/news/293827703.md) --- # Best Pharmaceutical Stocks To Watch Now - July 25th - As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner Eli Lilly and Company, AbbVie, Abbott Laboratories, Bristol Myers Squibb, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and sell prescription or over-the-counter medicines. For stock market investors, these stocks represent ownership in pharmaceutical businesses and may offer growth or income potential, but they can also carry risks related to clinical-trial results, regulatory approvals, competition, patent expirations, and drug pricing. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days. Get **Eli Lilly and Company** alerts: ## Eli Lilly and Company (LLY) Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. - 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend Read Our Latest Research Report on LLY ## AbbVie (ABBV) AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. - 3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound Read Our Latest Research Report on ABBV ## Abbott Laboratories (ABT) Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. Read Our Latest Research Report on ABT ## Bristol Myers Squibb (BMY) Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. Read Our Latest Research Report on BMY ## Gilead Sciences (GILD) Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. Read Our Latest Research Report on GILD ## Featured Stories - MarketBeat's Top Five Stocks to Own in July 2026 - Telecom Earnings Reveal a Sector That Finally Looks Healthier - Defense Earnings Show Readiness Now and Modernization Ahead - Why Palantir Investors Aren't Panicking While the Rest of AI Sells Off - MarketBeat Week in Review – 07/20- 07/24 - AMD and Cerbras Create A New Blueprint For Hardware _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Eli Lilly and Company Right Now? Before you consider Eli Lilly and Company, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list. While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [ABT.US](https://longbridge.com/en/quote/ABT.US.md) - [GILD.US](https://longbridge.com/en/quote/GILD.US.md) - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) - [BMY.US](https://longbridge.com/en/quote/BMY.US.md) - [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md) - [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md) - [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md) - [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md) - [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md) - [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md) - [PLTR.US](https://longbridge.com/en/quote/PLTR.US.md) - [AMD.US](https://longbridge.com/en/quote/AMD.US.md) - [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md) ## Related News & Research - [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md) - [Lilly Targets Early 2027 Filing for Next Obesity Drug](https://longbridge.com/en/news/293649982.md) - [Israel "Izzy" Englander increased his position in this pharma stock by 780%. Does he know something Wall Street doesn't?](https://longbridge.com/en/news/293842675.md) - [Bristol-Myers Squibb Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/294214143.md) - [Eli Lilly's Retatrutide Meets Primary Endpoint In Phase 3 TRIUMPH-2 And TRIUMPH-3 Trials](https://longbridge.com/en/news/293605576.md)